Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)

NCT02880943 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Clear-cell Metastatic Renal Cell Carcinoma
Bone Metastases

Interventions

DRUG: XOFIGO

Sponsor

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie